LQDA Liquidia Corporation
LQDA Liquidia Corporation
Healthcare · Drug Manufacturers - Specialty & Generic
Desk view
Market read
POC $29.41 · VWAP $45.05 · -23.7% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $17.8M sold last open-market sell Bloch Stephen M
Cluster CEO, CFO + 8 others sold $9.3M, Oct 7–13
Coverage
1 watchlist
LQDA Price Structure
Loading timeframes…
Peers
Every watchlist LQDA belongs to, members best 30-day change first — LQDA highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported EPS $0.74 versus analyst consensus of $0.84 (-11.5%).
full note →Against street estimates
How LQDA's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about LQDA from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 17
- (LQDA.O) | Stock Price & Latest News | Reuters
- Recent Articles by Liquidia Technologies, Inc. - FINVIZ.com
- Liquidia Share Price Today | NASDAQ: LQDA - Investing.com IN
- LQDA Stock Price Quote | Morningstar
- Liquidia (LQDA) Shares Rise After Strong Q1 Earnings and Revenue Beat
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
LQDA research tape
61 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.